Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2016

23.08.2016 | Editorial

Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Excerpt

The older leading concept concerning ascites formation postulates an imbalance of oncotic and hydrostatic forces, with portal pressure pushing fluid into the peritoneal cavity opposed by the serum colloid osmotic pressure generated by albumin. When hydrostatic exceed oncotic forces, the abdominal cavity fills with fluid until a counterbalancing increase in abdominal pressure prevents further ascites formation. Furthermore, patients with ascites are almost perfectly separated from those without ascites on the basis of portal pressure (relative to the cardiac pressure) and serum albumin concentration [1] seeming to support this concept. According to this model, decreased intra-abdominal pressure due to fluid removal by paracentesis promotes fluid movement into the peritoneal cavity at the expense of the intravascular compartment, potentially resulting in catastrophic hypotension and renal failure. Since these events were thought to occur soon after paracentesis, the prevailing recommendation was for <2 L to be removed at any one time. Harmful effects from paracentesis were considered likely despite a large global clinical experience that had not identified a high incidence of hypotension or renal failure due to a common and routine clinical procedure. …
Literatur
1.
Zurück zum Zitat Cerrick GR, Kerr DNA, Read AE, Sherlock S. Colloid osmotic pressure and hydrostatic pressure relationships in the formation of ascites in hepatic cirrhosis. Clin Sci. 1960;19:361–371. Cerrick GR, Kerr DNA, Read AE, Sherlock S. Colloid osmotic pressure and hydrostatic pressure relationships in the formation of ascites in hepatic cirrhosis. Clin Sci. 1960;19:361–371.
2.
Zurück zum Zitat Hoefs JC. Serum protein concentration and portal pressure determines the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med. 1983;102:260–273.PubMed Hoefs JC. Serum protein concentration and portal pressure determines the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med. 1983;102:260–273.PubMed
3.
Zurück zum Zitat Hoefs JC. The mechanism of ascitic fluid protein concentration increase during diuresis in patients with chronic liver disease. Am J Gastroenterol. 1981;76:423–431.PubMed Hoefs JC. The mechanism of ascitic fluid protein concentration increase during diuresis in patients with chronic liver disease. Am J Gastroenterol. 1981;76:423–431.PubMed
4.
Zurück zum Zitat Pare P, Talbot J, Hoefs JC. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites. Gastroenterology. 1984;85:240–244. Pare P, Talbot J, Hoefs JC. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites. Gastroenterology. 1984;85:240–244.
5.
Zurück zum Zitat Hoefs JC. Globulin correction of albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradients. Hepatology. 1992;16:396–403.CrossRefPubMed Hoefs JC. Globulin correction of albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradients. Hepatology. 1992;16:396–403.CrossRefPubMed
6.
Zurück zum Zitat Reynolds TB. Therapeutic paracentesis: have we come full circle? Gastroenterology. 1987;93:386–388.CrossRefPubMed Reynolds TB. Therapeutic paracentesis: have we come full circle? Gastroenterology. 1987;93:386–388.CrossRefPubMed
7.
Zurück zum Zitat Gines P, Arroyo V, Quintero E, et al. Comparison between paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of randomized study. Gastroenterology. 1987;93:234–241.CrossRefPubMed Gines P, Arroyo V, Quintero E, et al. Comparison between paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of randomized study. Gastroenterology. 1987;93:234–241.CrossRefPubMed
8.
Zurück zum Zitat Ruiz-del-Arbol L, Monescillo A, Jimenéz W, Garcia-Plaza A, Arroyo V, Rodés J. Paracentesis induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology. 1997;113:579–586.CrossRefPubMed Ruiz-del-Arbol L, Monescillo A, Jimenéz W, Garcia-Plaza A, Arroyo V, Rodés J. Paracentesis induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology. 1997;113:579–586.CrossRefPubMed
9.
Zurück zum Zitat Ginès P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;94:1493–1502.CrossRefPubMed Ginès P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;94:1493–1502.CrossRefPubMed
10.
Zurück zum Zitat Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–409.CrossRefPubMed Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–409.CrossRefPubMed
11.
Zurück zum Zitat Tan HK, James PD, Wong F. Albumin may prevent the morbidity of paracentesis-induced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study. Dig Dis Sci. (Epub ahead of print.) doi:10.1007/s10620-016-4140-3. Tan HK, James PD, Wong F. Albumin may prevent the morbidity of paracentesis-induced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study. Dig Dis Sci. (Epub ahead of print.) doi:10.​1007/​s10620-016-4140-3.
12.
Zurück zum Zitat Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–2107.CrossRefPubMed Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–2107.CrossRefPubMed
13.
Zurück zum Zitat Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55:1172.CrossRefPubMed Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55:1172.CrossRefPubMed
14.
Zurück zum Zitat Sersté T, Francoz C, Durand F, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: across-over study. J Hepatol. 2011;55:794–797.CrossRefPubMed Sersté T, Francoz C, Durand F, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: across-over study. J Hepatol. 2011;55:794–797.CrossRefPubMed
15.
Zurück zum Zitat Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol. 1997;92:394–399.PubMed Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol. 1997;92:394–399.PubMed
Metadaten
Titel
Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?
Publikationsdatum
23.08.2016
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4248-5

Weitere Artikel der Ausgabe 10/2016

Digestive Diseases and Sciences 10/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.